What is the appropriate next dose of venlafaxine (Effexor) for a patient currently taking 37.5 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Dose of Venlafaxine After 37.5 mg

The next dose is 75 mg daily, which should be initiated after at least 4 days at the current 37.5 mg dose. 1

Standard Titration Protocol

For patients currently on 37.5 mg daily, increase to 75 mg daily as the next step. 1 The FDA-approved dosing schedule specifies:

  • Starting dose: 75 mg/day (divided into 2-3 doses for immediate-release) 1
  • Dose increments: Up to 75 mg/day increases 1
  • Minimum interval between increases: At least 4 days 1

Since your patient is on 37.5 mg (half the standard starting dose), the logical next step is to reach the recommended initial therapeutic dose of 75 mg daily. 1

Target Therapeutic Dose

The therapeutic target is 150 mg/day, which typically requires 2-4 weeks to achieve. 2, 3 The recommended titration schedule to reach this target:

  • Week 1: 75 mg/day 2
  • Week 2: Increase to 150 mg/day (target achieved) 2
  • Weeks 3-6: Maintain 150 mg/day for a complete therapeutic trial of 4-6 weeks 2

Using 75 mg weekly increments allows you to reach therapeutic dosing in 1-2 weeks, compared to 3-4 weeks with smaller 37.5 mg increments. 2

Formulation Considerations

Extended-release (XR) formulation is preferred for once-daily dosing and improved tolerability. 2, 3 The XR formulation:

  • Reduces peak-related side effects like nausea 2
  • Improves adherence with once-daily dosing 2
  • Has lower risk of discontinuation syndrome with missed doses 2

Safety Monitoring

Measure blood pressure before each dose increase, particularly as you approach doses >200 mg/day. 2, 3 Venlafaxine causes dose-dependent blood pressure elevations. 2, 3

Exercise caution in patients with cardiac disease due to rare reports of conduction abnormalities. 2, 3

Common Pitfall to Avoid

The most common adverse event is nausea, which peaks during the first 2 weeks of treatment. 4 Reassure patients that nausea typically resolves and has low likelihood of developing after the initial 2-week period. 4

Maximum Dosing

If 150 mg/day proves insufficient after a 4-6 week trial, doses can be increased:

  • Outpatient maximum: 225 mg/day for most patients 1
  • Severely depressed inpatients: Up to 375 mg/day may be considered 1
  • Dose increases: Continue using 75 mg increments at minimum 4-day intervals 1

References

Guideline

Venlafaxine Titration to a Target Dose of 150 mg Daily

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Venlafaxine Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.